课题基金 / 基金详情

Activation of a DNA damage pathway by HIV-1 vpr

Activation of a DNA damage pathway by HIV-1 vpr
HIV-1 vpr 激活 DNA 损伤途径
批准号:
6666775
负责人:
VICENTE PLANELLES
金额:
$22.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-30 至 2005-08-31

项目摘要

项目成果

VICENTE PLANELLES的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The human immunodeficiency virus type-1 (HIV-1) encodes four accessory genes that regulate various aspects of the host cell biology. The vpr gene encodes a 96-amino acid protein (Vpr) that causes cell cycle arrest in G2 and apoptosis in the infected lymphocytes. The cellular pathways leading to Vpr-induced arrest and apoptosis can be activated in most mammalian cell types and are therefore, thought to be evolutionarily conserved. Vpr presumably utilizes cellular signaling pathways to induce its cytostatic and cytotoxic effects. Several studies have indicated that the effects of Vpr on the cell are similar to the effects of genotoxic drugs and other DNA damaging agents, such as radiation. However, we previously demonstrated that a major cellular protein involved in the response to genotoxic agents, p53, was not necessary for mediating the effects of Vpr. In the present study, we examined a recently identified DNA damage-signaling protein (the ATM- and Rad3-related protein, ATR) for its potential role in the induction of G2 arrest by Vpr. We show that inhibition of ATR by genetic means or with pharmacological inhibitors abrogates Vpr-induced cell cycle arrest in mammalian cells. ATR is a serine-threonine kinase that becomes activated in response to DNA damage. Activation of ATR typically results in direct phosphorylation of its target, the Chkl kinase. We detected phosphorylation of Chkl in response to Vpr expression. Since Chkl activation results in inactivation of Cdc2, our observations are consistent with the notion that the Vpr-induced cell cycle arrest involves an ATR-dependent stress-response pathway that leads to G2 arrest. By inhibiting ATR, we demonstrated suppression of another function of vpr, transactivation of the viral promoter. These observations may have important ramifications in the area of anti-HIV therapy. The goal of this proposal is to elucidate the specific steps of the DNA-response pathway that are activated by Vpr, and to compare such steps with the physiological activator, DNA damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of HIV-1 Transcription by CPSF6 and PP2A
  • 批准号:
    10693519
  • 项目类别:
  • 资助金额:
    $23.1万
  • 财政年份:
    2023
  • 负责人:
    VICENTE PLANELLES
  • 依托单位:
CRISPR/Cas9 technology toward understanding HIV latency in primary cells
  • 批准号:
    9203550
  • 项目类别:
  • 资助金额:
    $22.65万
  • 财政年份:
    2016
  • 负责人:
    VICENTE PLANELLES
  • 依托单位:
CRISPR/Cas9 technology toward understanding HIV latency in primary cells
  • 批准号:
    9303273
  • 项目类别:
  • 资助金额:
    $18.94万
  • 财政年份:
    2016
  • 负责人:
    VICENTE PLANELLES
  • 依托单位:
Preclinical Development of Ingenol and HDACi Toward HIV Eradication
  • 批准号:
    9049020
  • 项目类别:
  • 资助金额:
    $22.35万
  • 财政年份:
    2015
  • 负责人:
    VICENTE PLANELLES
  • 依托单位: